Conclusions:
The relatively small amount of drug transferred in breast milk and the lack of reported adverse effects along with the known benefits of breastfeeding may outweigh the risk of drug exposures in the transplant population.
The threshold for determining the level of exposure of an immunosuppressive agent that is acceptable is not known at present.
Continued study and follow-up of all breast-fed transplant recipient offspring is warranted.
Centers are encouraged to report all pregnancies in transplant recipients to the NTRR
